Skip to main
DOC
DOC logo

DOC Stock Forecast & Price Target

DOC Analyst Ratings

Based on 34 analyst ratings
Buy
Strong Buy 32%
Buy 38%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Healthpeak Properties has demonstrated strong asset performance in 2023 with solid growth resulting from the easing of pandemic-related challenges. The company has achieved significant leasing success in its life science segment, with notable metrics indicating a growth trajectory that could surpass 3.0% organic growth in 2025 and 2026, while also positioning for healthy FFOPS and AFFOPS growth of 4.0%/3.4% and 5.0%/2.7% respectively. Additionally, the ongoing momentum in lab leasing and the potential recovery of its Continuing Care Retirement Community (CCRC) business to pre-COVID levels are expected to enhance overall market valuations and solidify the financial outlook for Healthpeak Properties.

Bears say

Healthpeak Properties faces a challenging outlook due to anticipated operating trend weaknesses in the life science sector, likely resulting in reduced organic growth and caution in capital deployment. Current financial metrics indicate a net debt to EBITDA ratio of 5.1x, which, while below the long-term target, reflects potential strain given expected supply pressures that could lead to increased tenant improvement costs, lower rental rates, and occupancy declines over the next year. Moreover, rising raw material and labor costs associated with development activities could further hinder investment returns and exacerbate operational disruptions within the portfolio.

DOC has been analyzed by 34 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 38% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Healthpeak Properties Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Healthpeak Properties Inc (DOC) Forecast

Analysts have given DOC a Buy based on their latest research and market trends.

According to 34 analysts, DOC has a Buy consensus rating as of Jun 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Healthpeak Properties Inc (DOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.